A recent pilot study highlights the safety of intravenous BPC-157 in humans, reinforcing its potential for treating musculoskeletal injuries and accelerating tissue repair. New research validates the ...
A 2023 pilot study shows promising safety for IV BPC-157 in treating musculoskeletal injuries, but regulatory hurdles and off-label use raise concerns. Recent research highlights BPC-157’s poten...